Braden M. Leonard - 19 Mar 2024 Form 4 Insider Report for Cyteir Therapeutics, Inc.

Role: 10%+ Owner
Signature: /s/ Braden Michael Leonard
Issuer symbol: N/A
Transactions as of: 19 Mar 2024
Net transactions value: +$342,469
Form type: 4
Filing time: 19 Mar 2024, 16:19:39 UTC
Previous filing: 19 Mar 2024
Next filing: 25 Mar 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CYT	Common Stock, par value $0.001 per share	Purchase	$342,469	+113,777	+3.4%	$3.01	3,483,464	18 Mar 2024	Holding of BML Investment Partners, L.P	F1
holding	CYT	Common Stock, par value $0.001 per share						335,000	19 Mar 2024	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	BML Capital Management, LLC ("BML Capital") serves as the general partner of BML Investment Partners, L.P., a Delaware limited partnership (the "Fund"), which is the direct owner of the subject shares. Mr. Leonard is the managing member of BML Capital, and exercises investment and voting control over the subject shares. Accordingly, shares owned directly by the Fund may be regarded as being beneficially owned by Mr. Leonard. Notwithstanding, Mr. Leonard disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein.New Footnote

Content

BML Capital Management, LLC ("BML Capital") serves as the general partner of BML Investment Partners, L.P., a Delaware limited partnership (the "Fund"), which is the direct owner of the subject shares. Mr. Leonard is the managing member of BML Capital, and exercises investment and voting control over the subject shares. Accordingly, shares owned directly by the Fund may be regarded as being beneficially owned by Mr. Leonard. Notwithstanding, Mr. Leonard disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein.New Footnote